CLONAL EVOLUTION OF TUMOR-CELL POPULATIONS

被引：4977
|
作者：
NOWELL, PC [1 ]
机构：
[1] UNIV PENN,SCH MED,PHILADELPHIA,PA 19174
来源：
SCIENCE | 1976年 / 194卷 / 4260期
关键词：
D O I：
10.1126/science.959840
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：23 / 28
页数：6
相关论文
共 50 条
  • [41] TUMOR-CELL PROLIFERATION
    GELFANT, S
    [J]. JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1978, : 295 - 295
  • [42] TUMOR-CELL SOCIETIES
    HEPPNER, GH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (09) : 648 - 649
  • [43] TUMOR-CELL KINETICS
    RICHES, AC
    [J]. JOURNAL OF ANATOMY, 1977, 123 (FEB) : 242 - 242
  • [44] TUMOR-CELL DIVERSITY
    不详
    [J]. LANCET, 1983, 1 (8318): : 222 - 222
  • [45] TUMOR-CELL CULTURE
    MOYER, MP
    [J]. ONCOGENE TECHNIQUES, 1995, 254 : 153 - 165
  • [46] TUMOR-CELL RESISTANCE
    ROSENBLUM, ML
    GEROSA, MA
    BODELL, WJ
    TALCOTT, RL
    [J]. PROGRESS IN EXPERIMENTAL TUMOR RESEARCH, 1984, 27 : 191 - 214
  • [47] The Optimal Sequencing Depth of Tumor Biopsies for Identifying Clonal Cell Populations
    Tabatabaeifar, Siavosh
    Larsen, Martin J.
    Thomassen, Mads
    Larsen, Stine R.
    Kruse, Torben A.
    Sorensen, Jens A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (05): : 790 - 795
  • [48] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ACTIVITY RELEASED BY CLONAL TUMOR-CELL POPULATIONS ISOLATED DURING THE GROWTH OF A MURINE MAMMARY ADENOCARCINOMA
    ALONSO, DF
    FARIAS, EVF
    JOFFE, EDBD
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1994, 13 (03): : 211 - 216
  • [49] TUMOR-ASSOCIATED ANTIGENIC DIFFERENCES BETWEEN THE PRIMARY AND THE DESCENDANT METASTATIC TUMOR-CELL POPULATIONS
    GORELIK, E
    FOGEL, M
    SEGAL, S
    FELDMAN, M
    [J]. JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1979, : 184 - 184
  • [50] TUMOR-ASSOCIATED ANTIGENIC DIFFERENCES BETWEEN THE PRIMARY AND THE DESCENDANT METASTATIC TUMOR-CELL POPULATIONS
    GORELIK, E
    FOGEL, M
    SEGAL, S
    FELDMAN, M
    [J]. JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1979, 12 (03): : 385 - 402
12345